No association between the GSTM1 null genotype and risk of renal cell carcinoma: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3109-3112

  Liu, Rui ^a   Wang, Xiao Hua ^a   Liu, Li ^a   Zhou, Qiang ^a  

^a SUINING CENTRAL HOSPITAL   (China)

Author keywords

GSTM1; Meta analysis; Polymorphism; Renal cell carcinoma

Indexed keywords

EID: 84873587661     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3109     Document Type: Article

References (29)

1. Ahmad ST, Arjumand W, Seth A, et al (2012). Impact of glutathione transferase M1, T1, and P1 gene polymorphisms in the genetic susceptibility of North Indian population to renal cell carcinoma. DNA Cell Biol, 31, 636-43.
2. Attia J, Thakkinstian A, D'Este C (2003). Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol, 56, 297-303.
3. Bex A, Gore M, Mulders P, et al (2012). Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care. BJU Int, [Publishing in progress].
4. Bruning T, Lammert M, Kempkes M, et al (1997). Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch Toxicol, 71, 596-9.
5. Buzio L, De Palma G, Mozzoni P, et al (2003). Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals. Occup Environ Med, 60, 789-93.
6. Chen J, Cheng M, Yi L, et al (2011). Relationship between CYP1A1 genetic polymorphisms and renal cancer in China. Asian Pac J Cancer Prev, 12, 2163-6.
7. De Martino M, Klatte T, Schatzl G, et al (2010). Renal cell carcinoma Fuhrman grade and histological subtype correlate with complete polymorphic deletion of glutathione S-transferase M1 gene. J Urol, 183, 878-83.
8. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
9. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
10. Hayes JD, Flanagan JU, Jowsey IR (2005). Glutathione transferases. Annu Rev Pharmacol Toxicol, 45, 51-88.
11. Hayes JD, Strange RC (2000). Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology, 61, 154-66.
12. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
13. Jonasch E, Futreal A, Davis I, et al (2012). State-of-the-science: An update on renal cell carcinoma. Mol Cancer Res, [Publishing in progress].
14. Kumar V, Murthy AK, Suresh KP (2011). Glutathione S-transferase M1 and T1 status and the risk of laryngeal cancer: a meta-analysis. Asian Pac J Cancer Prev, 12, 2221-6.
15. Liu Y, Xu LZ (2012). Meta-analysis of association between GSTM1 gene polymorphism and cervical cancer. Asian Pac J Trop Med, 5, 480-4.
16. Longuemaux S, Delomenie C, Gallou C, et al (1999). Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res, 59, 2903-8.
17. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
18. Moore LE, Brennan P, Karami S, et al (2007). Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis, 28, 1960-4.
19. Muellerleile P, Mullen B (2006). Sufficiency and stability of evidence for public health interventions using cumulative meta-analysis. Am J Public Health, 96, 515-22.
20. Murai M, Oya M (2004). Renal cell carcinoma: etiology, incidence and epidemiology. Curr Opin Urol, 14, 229-33.
21. Petitti DB (2000) Meta-analysis, decision analysis, and cost effectiveness analysis: methods for quantitative synthesis in medicine(2nded). New York, NY: Oxford University Press.
22. Salinas-Sanchez AS, Sanchez-Sanchez F, Donate-Moreno MJ, et al (2012). GSTT1, GSTM1, and CYP1B1 gene polymorphisms and susceptibility to sporadic renal cell cancer. Urol Oncol, [Publishing in progress].
23. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
24. Simic T, Savic-Radojevic A, Pljesa-Ercegovac M, et al (2009). Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol, 6, 281-9.
25. Sweeney C, Farrow DC, Schwartz SM, et al (2000). Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev, 9, 449-54.
26. Wang B, Huang G, Wang D, et al (2010). Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol, 53, 508-18.
27. Zhang R, Xu G, Chen W, et al (2011). Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies. Mol Biol Rep, 38, 2491-7.
28. Zhu Y, He Q, Wang J, et al (2012). The association between GSTM1 polymorphism and gastric cancer risk: a meta-analysis. Mol Biol Rep, 39, 685-91.
29. Zintzaras E, Lau J (2008). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol, 61, 634-45.